A Descriptive Analysis of Acute Viral Hepatitis Using a Database with Electronic Medical Records and Claims Data

Overview

Journal Ann Clin Epidemiol

Specialty General Medicine

Date 2024 Mar 20

PMID 38504953

Authors

Hayato Yamana

Kazumi Yamasaki

Taisuke Jo

Hiroshi Yatsuhashi

Hideo Yasunaga

Affiliations

Soon will be listed here.

Citing Articles

Leveraging Administrative Health Databases to Address Health Challenges in Farming Populations: Scoping Review and Bibliometric Analysis (1975-2024).

Petit P, Vuillerme N JMIR Public Health Surveill. 2025; 11:e62939.

PMID: 39787587 PMC: 11757986. DOI: 10.2196/62939.

References

Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y . Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res. 2011; 41(9):805-12. DOI: 10.1111/j.1872-034X.2011.00860.x. View

Tillmann H, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C . Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006; 13(4):256-63. DOI: 10.1111/j.1365-2893.2005.00695.x. View

Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S . Acute liver disease in Japan: a nationwide analysis of the Japanese Diagnosis Procedure Combination database. J Gastroenterol. 2013; 49(3):547-54. DOI: 10.1007/s00535-013-0843-9. View

Yu J, Sun L, Zhao Y, Kang P, Li S . The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci. 2009; 55(3):775-83. DOI: 10.1007/s10620-009-1060-5. View

Miyake Y, Iwasaki Y, Takaki A, Fujioka S, Takaguchi K, Ikeda H . Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med. 2008; 47(14):1293-9. DOI: 10.2169/internalmedicine.47.1061. View

Takeuchi M, Inokuchi S, Kimura T, Eguchi N, Kawakami K, Takahashi T . Descriptive epidemiology of COVID-19 in Japan 2020: insights from a multihospital database. Ann Clin Epidemiol. 2024; 5(1):5-12. PMC: 10760473. DOI: 10.37737/ace.23002. View

Jochum C, Gieseler R, Gawlista I, Fiedler A, Manka P, Saner F . Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion. 2009; 80(4):235-40. DOI: 10.1159/000236009. View

Ito K, Yotsuyanagi H, Yatsuhashi H, Karino Y, Takikawa Y, Saito T . Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2013; 59(1):89-97. DOI: 10.1002/hep.26635. View

Sako A, Yasunaga H, Horiguchi H, Hashimoto H, Masaki N, Matsuda S . Acute hepatitis B in Japan: Incidence, clinical practices and health policy. Hepatol Res. 2010; 41(1):39-45. DOI: 10.1111/j.1872-034X.2010.00745.x. View

10.

Sterling R, Wahed A, Cloherty G, Hoofnagle J, Lee W . Acute Hepatitis B Virus Infection in North American Adults. Clin Gastroenterol Hepatol. 2022; 21(7):1881-1892.e4. PMC: 10017371. DOI: 10.1016/j.cgh.2022.09.004. View

11.

Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C . A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2006; 45(1):97-101. DOI: 10.1002/hep.21486. View